SEC Company Response from BNB PLUS CORP. (BNBX) (CIK 0000744452) (BNBX) — Dec 12, 2016
BNB PLUS CORP. (BNBX) (CIK 0000744452)
Date: Dec. 12, 2016 · CIK: 0000744452 · Accession: 0001571049-16-020558
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-214920
Letter
Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, New York 11790
(631) 240-8800
December 12, 2016
Via EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Gregory Dundas
Re:
Applied DNA Sciences, Inc.
Registration Statement on Form S-3
Filed December 6, 2016
File No. 333-214920
Ladies and Gentlemen:
Applied DNA Sciences, Inc. a Delaware corporation (the “Company”), hereby requests, pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), that the effective date of the Company’s Registration Statement on Form S-3, Registration No. 333-214920 (the “Registration Statement”), be accelerated so that the Company’s Registration Statement will become effective, at 2:00pm Washington, D.C. time on December 13, 2016, or as soon thereafter as practicable. In this regard, the Company is aware of its obligations under the Securities Act as they relate to the above-referenced Registration Statement and acknowledges that:
· should the U.S. Securities and Exchange Commission (“Commission”) or its Staff (“Staff”), acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
· the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
· the Company may not assert Staff comments or the declaration of the Registration Statement’s effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Merrill Kraines of Pepper Hamilton LLP at 212.808.2711.
Very truly yours,
Applied DNA Sciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, New York 11790
(631) 240-8800
December 12, 2016
Via EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Gregory Dundas
Re:
Applied DNA Sciences, Inc.
Registration Statement on Form S-3
Filed December 6, 2016
File No. 333-214920
Ladies and Gentlemen:
Applied DNA Sciences, Inc. a Delaware corporation
(the “Company”), hereby requests, pursuant to Rule 461 under the Securities Act of 1933, as amended (the
“Securities Act”), that the effective date of the Company’s Registration Statement on Form S-3,
Registration No. 333-214920 (the “Registration Statement”), be accelerated so that the Company’s
Registration Statement will become effective, at 2:00pm Washington, D.C. time on December 13, 2016, or as soon thereafter as practicable.
In this regard, the Company is aware of its obligations under the Securities Act as they relate to the above-referenced Registration
Statement and acknowledges that:
· should the U.S. Securities and Exchange Commission (“Commission”) or its Staff (“Staff”),
acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from
taking any action with respect to the Registration Statement;
· the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement
effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration
Statement; and
· the Company may not assert Staff comments or the declaration of the Registration Statement’s effectiveness as a defense
in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
It would be appreciated if, as soon as
the Registration Statement is declared effective, you would so inform Merrill Kraines of Pepper Hamilton LLP at 212.808.2711.
Very truly yours,
Applied DNA Sciences, Inc.
By: /s/ Beth Jantzen
Name: Beth Jantzen
Title: Chief Financial Officer